These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 15225222

  • 1. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 2. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C, Cavallo R, Bergallo M, Giacchino F, Bollero C, Negro Ponzi A, Cavallo G.
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [Abstract] [Full Text] [Related]

  • 3. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C, Giacchino F, Bergallo M, Bonello F, Bollero C, Segoloni GP, Cavallo R.
    G Ital Nefrol; 2003 Apr; 20(2):170-5. PubMed ID: 12746803
    [Abstract] [Full Text] [Related]

  • 4. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [Abstract] [Full Text] [Related]

  • 5. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.
    Clin Transplant; 2006 Oct; 20(3):389-93. PubMed ID: 16824159
    [Abstract] [Full Text] [Related]

  • 6. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 7. Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation.
    Ruf S, Behnke-Hall K, Gruhn B, Bauer J, Horn M, Beck J, Reiter A, Wagner HJ.
    J Clin Virol; 2012 Mar; 53(3):186-94. PubMed ID: 22182950
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Mar; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 9. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 10. Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.
    Jang JY, Kim KM, Lee YJ, Lee SG, Chi HS.
    Transplant Proc; 2008 Oct; 40(8):2546-8. PubMed ID: 18929796
    [Abstract] [Full Text] [Related]

  • 11. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 12. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K, Hassan J, Staines A, Coughlan S, Holder P, Tuite G, McCormick AP, Traynor O, Hall WW, Connell J.
    Liver Transpl; 2011 Dec; 17(12):1420-6. PubMed ID: 21837744
    [Abstract] [Full Text] [Related]

  • 14. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J, Danielian S, Ibañez J, Turconi A, Cuarterolo M, Zelazko M, Niesters Hubert GM.
    J Clin Virol; 2004 Sep; 31(1):58-65. PubMed ID: 15288615
    [Abstract] [Full Text] [Related]

  • 15. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD.
    D'Antiga L, Del Rizzo M, Mengoli C, Cillo U, Guariso G, Zancan L.
    Liver Transpl; 2007 Mar; 13(3):343-8. PubMed ID: 17154402
    [Abstract] [Full Text] [Related]

  • 16. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
    Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG.
    Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434
    [Abstract] [Full Text] [Related]

  • 17. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease.
    Carpentier L, Tapiero B, Alvarez F, Viau C, Alfieri C.
    J Infect Dis; 2003 Dec 15; 188(12):1853-64. PubMed ID: 14673764
    [Abstract] [Full Text] [Related]

  • 19. Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation.
    Chen HS, Ho MC, Hu RH, Wu JF, Chen HL, Ni YH, Hsu HY, Jeng YM, Chang MH.
    J Formos Med Assoc; 2019 Sep 15; 118(9):1362-1368. PubMed ID: 30612881
    [Abstract] [Full Text] [Related]

  • 20. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct 15; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.